MedPath

STRAGEN-FRANCE

🇫🇷France
Ownership
-
Employees
-
Market Cap
-
Website

First-In-Human PainCart Study for STR-324

Phase 1
Completed
Conditions
Pain
Interventions
Drug: Placebo
Drug: STR-324 Dose Level A
Drug: STR-324 Dose Level B
Drug: STR-324 Dose Level C
Drug: STR-324 Dose Level 1
Drug: STR-324 Dose Level 2
Drug: STR-324 Dose Level 3
Drug: STR-324 Dose Level 4
Drug: STR-324 Dose Level 5
Drug: STR-324 Dose Level 6
Drug: STR-324 Dose Level 7
Drug: STR-324 Dose Level 8
First Posted Date
2018-02-12
Last Posted Date
2018-12-12
Lead Sponsor
Stragen France
Target Recruit Count
78
Registration Number
NCT03430232
Locations
🇳🇱

CHDR, Leiden, Netherlands

© Copyright 2025. All Rights Reserved by MedPath